Jim Simons’s Mesa Laboratories MLAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.79M Buy
31,600
+28,100
+803% +$2.42M ﹤0.01% 1698
2025
Q4
$275K Sell
3,500
-7,400
-68% -$563K ﹤0.01% 2793
2025
Q3
$730K Sell
10,900
-57,127
-84% -$4.11M ﹤0.01% 2641
2025
Q2
$6.41M Buy
68,027
+59,827
+730% +$6.57M 0.01% 1359
2025
Q1
$973K Buy
8,200
+700
+9% +$95.4K ﹤0.01% 2448
2024
Q4
$989K Sell
7,500
-5,900
-44% -$724K ﹤0.01% 2504
2024
Q3
$1.74M Buy
13,400
+11,000
+458% +$1.29M ﹤0.01% 2112
2024
Q2
$208K Sell
2,400
-13,700
-85% -$1.43M ﹤0.01% 3033
2024
Q1
$1.77M Sell
16,100
-14,300
-47% -$1.44M ﹤0.01% 2115
2023
Q4
$3.19M Buy
30,400
+21,600
+245% +$2.1M ﹤0.01% 1646
2023
Q3
$925K Sell
8,800
-14,200
-62% -$1.82M ﹤0.01% 2361
2023
Q2
$2.96M Buy
23,000
+13,300
+137% +$2.03M ﹤0.01% 1750
2023
Q1
$1.7M Sell
9,700
-8,234
-46% -$1.48M ﹤0.01% 2130
2022
Q4
$2.98M Buy
17,934
+9,734
+119% +$1.53M ﹤0.01% 1823
2022
Q3
$1.16M Sell
8,200
-4,900
-37% -$894K ﹤0.01% 2405
2022
Q2
$2.67M Hold
13,100
﹤0.01% 1979
2022
Q1
$3.34M Sell
13,100
-2,782
-18% -$756K ﹤0.01% 1853
2021
Q4
$5.21M Sell
15,882
-11,218
-41% -$3.52M 0.01% 1506
2021
Q3
$8.19M Buy
27,100
+3,400
+14% +$966K 0.01% 1149
2021
Q2
$6.43M Buy
23,700
+11,800
+99% +$2.99M 0.01% 1479
2021
Q1
$2.9M Sell
11,900
-2,200
-16% -$605K ﹤0.01% 1987
2020
Q4
$4.04M Sell
14,100
-28,000
-67% -$7.7M ﹤0.01% 1723
2020
Q3
$10.7M Sell
42,100
-7,000
-14% -$1.66M 0.01% 1080
2020
Q2
$10.6M Buy
49,100
+15,200
+45% +$3.5M 0.01% 1180
2020
Q1
$7.66M Sell
33,900
-32,000
-49% -$7.89M 0.01% 1324
2019
Q4
$16.4M Sell
65,900
-14,600
-18% -$3.42M 0.01% 1118
2019
Q3
$19.1M Buy
80,500
+33,700
+72% +$7.79M 0.02% 984
2019
Q2
$11.4M Sell
46,800
-7,100
-13% -$1.65M 0.01% 1312
2019
Q1
$12.4M Sell
53,900
-8,400
-13% -$1.9M 0.01% 1244
2018
Q4
$13M Sell
62,300
-400
-0.6% -$78K 0.01% 1157
2018
Q3
$11.6M Buy
62,700
+200
+0.3% +$40.3K 0.01% 1263
2018
Q2
$13.2M Sell
62,500
-11,500
-16% -$2.01M 0.01% 1195
2018
Q1
$11M Sell
74,000
-4,600
-6% -$627K 0.01% 1308
2017
Q4
$9.77M Sell
78,600
-5,600
-7% -$783K 0.01% 1404
2017
Q3
$12.6M Sell
84,200
-3,071
-4% -$433K 0.01% 1185
2017
Q2
$12.5M Buy
87,271
+7,771
+10% +$1.1M 0.02% 1120
2017
Q1
$9.76M Sell
79,500
-3,800
-5% -$465K 0.01% 1265
2016
Q4
$10.2M Sell
83,300
-10,859
-12% -$1.36M 0.02% 1205
2016
Q3
$10.8M Sell
94,159
-7,441
-7% -$848K 0.02% 1107
2016
Q2
$12.5M Sell
101,600
-34,800
-26% -$3.75M 0.02% 1002
2016
Q1
$13.1M Sell
136,400
-2,199
-2% -$198K 0.03% 944
2015
Q4
$13.8M Buy
138,599
+4,199
+3% +$449K 0.03% 766
2015
Q3
$15M Buy
134,400
+207
+0.2% +$21.9K 0.04% 665
2015
Q2
$11.9M Sell
134,193
-5,907
-4% -$499K 0.03% 836
2015
Q1
$10.1M Sell
140,100
-7,124
-5% -$531K 0.02% 931
2014
Q4
$11.4M Sell
147,224
-20,576
-12% -$1.51M 0.03% 804
2014
Q3
$9.7M Buy
167,800
+7,200
+4% +$522K 0.03% 773
2014
Q2
$13.5M Buy
160,600
+26,457
+20% +$2.19M 0.03% 675
2014
Q1
$12.1M Buy
134,143
+7,955
+6% +$676K 0.03% 761
2013
Q4
$9.92M Buy
126,188
+14,988
+13% +$1.09M 0.02% 810
2013
Q3
$7.52M Buy
111,200
+22,000
+25% +$1.41M 0.02% 948
2013
Q2
$4.83M Buy
+89,200
New +$4.63M 0.01% 1120

Other funds holding MLAB

Jim Simons's MLAB Position: Q1 2026 in Review

Jim Simons increased its Mesa Laboratories (MLAB) stake by 803% in Q1 2026, buying an estimated $2.42M and bringing the position to 31,600 shares worth $2.79M. The position accounts for ﹤0.01% of the portfolio, ranked #1698.

Jim Simons first reported a position in MLAB in Q2 2013 and has held it in 52 quarters since. The position peaked at $19.1M in Q3 2019. 161 funds tracked by Wall St. Rank hold MLAB as of Q1 2026.

  • Jim Simons held 31,600 shares of Mesa Laboratories worth $2.79M as of Q1 2026.
  • Jim Simons bought 28,100 Mesa Laboratories shares in Q1 2026, an estimated $2.42M.
  • Mesa Laboratories made up ﹤0.01% of Jim Simons's portfolio in Q1 2026, its #1698 holding.
  • Jim Simons first reported a position in Mesa Laboratories in Q2 2013 and has held it in 52 quarters since.
  • Jim Simons's Mesa Laboratories position peaked at $19.1M in Q3 2019.
  • 161 funds tracked by Wall St. Rank held Mesa Laboratories as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.